Astrana Health [ASTH] vs HCA Healthcare [HCA] Detailed Stock Comparison
Astrana Health
NASDAQ
Loading...
HCA Healthcare
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Astrana Health wins in 4 metrics, HCA Healthcare wins in 15 metrics, with 0 ties. HCA Healthcare appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Astrana Health | HCA Healthcare | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 56.49 | 16.91 | HCA Healthcare |
| Price-to-Book Ratio | 1.92 | -76.81 | HCA Healthcare |
| Debt-to-Equity Ratio | 83.20 | -37.45 | HCA Healthcare |
| PEG Ratio | -1.08 | 0.68 | Astrana Health |
| EV/EBITDA | 13.84 | 9.70 | HCA Healthcare |
| Profit Margin (TTM) | 1.04% | 8.21% | HCA Healthcare |
| Operating Margin (TTM) | 3.11% | 15.95% | HCA Healthcare |
| EBITDA Margin (TTM) | 3.11% | 15.95% | HCA Healthcare |
| Return on Equity | 5.44% | 13,631.68% | HCA Healthcare |
| Return on Assets (TTM) | 3.25% | 11.84% | HCA Healthcare |
| Free Cash Flow (TTM) | $44.17M | $5.64B | HCA Healthcare |
| Dividend Yield | N/A | 0.54% | N/A |
| 1-Year Return | -37.72% | 3.98% | HCA Healthcare |
| Price-to-Sales Ratio (TTM) | 0.57 | 1.30 | Astrana Health |
| Enterprise Value | $1.37B | $140.58B | HCA Healthcare |
| EV/Revenue Ratio | 0.57 | 1.93 | Astrana Health |
| Gross Profit Margin (TTM) | 11.91% | 40.97% | HCA Healthcare |
| Revenue per Share (TTM) | $50 | $292 | HCA Healthcare |
| Earnings per Share (Diluted) | $0.53 | $23.81 | HCA Healthcare |
| Beta (Stock Volatility) | 0.86 | 1.40 | Astrana Health |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Astrana Health vs HCA Healthcare Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Astrana Health | 2.37% | 1.46% | 30.08% | 18.98% | -16.00% | -6.93% |
| HCA Healthcare | 0.16% | 2.70% | 10.89% | 5.88% | 27.76% | 35.77% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Astrana Health | -37.72% | -30.63% | 64.85% | 252.59% | 487.65% | 487.65% |
| HCA Healthcare | 3.98% | 97.22% | 197.27% | 355.15% | 1,199.04% | 1,199.04% |
Performance & Financial Health Analysis: Astrana Health vs HCA Healthcare
| Metric | ASTH | HCA |
|---|---|---|
| Market Information | ||
| Market Cap | $1.38B | $94.23B |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 632,930 | 1,145,712 |
| 90 Day Avg. Volume | 438,513 | 1,458,047 |
| Last Close | $30.68 | $404.92 |
| 52 Week Range | $21.20 - $63.20 | $289.98 - $417.14 |
| % from 52W High | -51.46% | -2.93% |
| All-Time High | $133.23 (Nov 15, 2021) | $417.14 (Oct 14, 2024) |
| % from All-Time High | -76.97% | -2.93% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.35% | 0.06% |
| Quarterly Earnings Growth | -0.51% | 0.13% |
| Financial Health | ||
| Profit Margin (TTM) | 0.01% | 0.08% |
| Operating Margin (TTM) | 0.03% | 0.16% |
| Return on Equity (TTM) | 0.05% | 136.32% |
| Debt to Equity (MRQ) | 83.20 | -37.45 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $15.58 | $-18.61 |
| Cash per Share (MRQ) | $6.85 | $4.45 |
| Operating Cash Flow (TTM) | $130.56M | $11.93B |
| Levered Free Cash Flow (TTM) | $97.63M | $5.59B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.54% |
| Last 12-Month Dividend | N/A | $2.04 |
Valuation & Enterprise Metrics Analysis: Astrana Health vs HCA Healthcare
| Metric | ASTH | HCA |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 56.49 | 16.91 |
| Forward P/E | 19.57 | 16.40 |
| PEG Ratio | -1.08 | 0.68 |
| Price to Sales (TTM) | 0.57 | 1.30 |
| Price to Book (MRQ) | 1.92 | -76.81 |
| Market Capitalization | ||
| Market Capitalization | $1.38B | $94.23B |
| Enterprise Value | $1.37B | $140.58B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.57 | 1.93 |
| Enterprise to EBITDA | 13.84 | 9.70 |
| Risk & Other Metrics | ||
| Beta | 0.86 | 1.40 |
| Book Value per Share (MRQ) | $15.58 | $-18.61 |
Financial Statements Comparison: Astrana Health vs HCA Healthcare
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ASTH | HCA |
|---|---|---|
| Revenue/Sales | $620.39M | $18.61B |
| Cost of Goods Sold | $549.06M | $10.98B |
| Gross Profit | $71.33M | $7.62B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $20.58M | $2.97B |
| EBITDA | $23.81M | $3.85B |
| Pre-Tax Income | $9.60M | $2.42B |
| Income Tax | $3.38M | $524.00M |
| Net Income (Profit) | $6.22M | $1.89B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ASTH | HCA |
|---|---|---|
| Cash & Equivalents | $258.52M | $1.06B |
| Total Current Assets | $613.27M | $16.26B |
| Total Current Liabilities | $361.27M | $13.63B |
| Long-Term Debt | $433.40M | $42.92B |
| Total Shareholders Equity | $517.71M | $-438.00M |
| Retained Earnings | $292.88M | $-3.16B |
| Property, Plant & Equipment | $47.55M | $65.81B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ASTH | HCA |
|---|---|---|
| Operating Cash Flow | $12.67M | $2.65B |
| Capital Expenditures | $-3.07M | $-991.00M |
| Free Cash Flow | $13.56M | $660.00M |
| Debt Repayment | $-428.38M | $-3.90B |
| Common Stock Repurchase | $-1.32M | $-2.51B |
Short Interest & Institutional Ownership Analysis
| Metric | ASTH | HCA |
|---|---|---|
| Shares Short | 1.61M | 4.06M |
| Short Ratio | 5.33 | 2.60 |
| Short % of Float | 0.06% | 0.02% |
| Average Daily Volume (10 Day) | 632,930 | 1,145,712 |
| Average Daily Volume (90 Day) | 438,513 | 1,458,047 |
| Shares Outstanding | 47.93M | 249.98M |
| Float Shares | 37.55M | 161.52M |
| % Held by Insiders | 0.22% | 0.31% |
| % Held by Institutions | 0.53% | 0.65% |
Dividend Analysis & Yield Comparison: Astrana Health vs HCA Healthcare
| Metric | ASTH | HCA |
|---|---|---|
| Last 12-Month Dividend | N/A | $2.04 |
| Last 12-Month Dividend Yield | N/A | 0.54% |
| 3-Year Avg Annual Dividend | N/A | $2.29 |
| 3-Year Avg Dividend Yield | N/A | 0.22% |
| 3-Year Total Dividends | N/A | $6.88 |
| Ex-Dividend Date | N/A | Mar 17, 2025 |